APSAD Sydney 2016 Conference


  Henry R. Kranzler, M.D. is Professor of Psychiatry at the University of Pennsylvania’s Perelman School of Medicine.

Dr. Kranzler’s research focuses on the genetics and pharmacological treatment of substance dependence. His research has been continuously supported since 1987 by grants from the U.S. National Institutes of Health. He has authored or co-authored nearly 500 journal articles, book chapters, and other publications, is a member of the editorial board of five peer-review journals, and is the Editor of Alcoholism: Clinical and Experimental Research.

His contributions to the pharmacological treatment of alcohol use disorder (AUD) include the first trial of a targeted (i.e., as-needed) medication, the first trial of a long-acting naltrexone formulation to reduce heavy drinking, and the identification of genetic moderators of response to treatment with a variety of medications. His current work focuses on the personalized treatment of AUD and smoking using a pharmacogenetics approach.